In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
MAHs can now also use the FAMHP’s post box address in product information

MAHs can now also use the FAMHP’s post box address in product information

by In2Pharma | Nov 4, 2019 | News

Belgium The address information of the FAMHP for reporting side effects in the document “Appendix V – ADR reporting details” of the QRD template has been revised. In addition to the known address, patients can now also use a post box address to report side...

Recent Posts

  • Update instructions for distribution of DHPC in Luxembourg
  • Diploma for the Responsible Person for Information and Publicity (RIP)
  • Update Procedure for MA applications in Luxembourg
  • Labeling Medicinal products
  • New clarification about Day 0 in local literature search published by EMA

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België